Hemorif 450 mg+50 mg (Tablet)
Unit Price: ৳ 8.06 (3 x 10: ৳ 241.80)
Strip Price: ৳ 80.60
Medicine Details
| Category | Details |
|---|---|
| Generic | Diosmin hesperidin |
| Company | Square pharmaceuticals plc |
| Also available as |
Indications
- Acute hemorrhoidal attacks
- Chronic hemorrhoidal disease
- Organic and functional chronic venous insufficiency of the lower limbs with the following symptoms: heavy legs, pain, nocturnal cramps
Composition
- Diosmin micronised BP 450 mg
- Hesperidin micronised INN 50 mg
- Diosmin micronised BP 900 mg
- Hesperidin micronised USP 100 mg
Pharmacology
- Phlebotonic drug
- Vascular protecting agent
- Reinforces venous tone
- Decreases venous capacitance
- Decreases venous distensibility
- Protects microcirculation
- Combats venous inflammation
- Normalizes capillary permeability
- Strengthens capillary resistance
- Improves lymphatic drainage
- Increases lymph flow
- Improves lymphatic drainage by increasing lymph flow and lymph oncotic pressure
Dosage
- 3 tablets twice daily for the first 4 days for acute hemorrhoidal attacks
- 2 tablets twice daily for three days for acute hemorrhoidal attacks
- 1 tablet twice daily for chronic hemorrhoids
- 1 tablet twice daily initially for seven days for chronic venous insufficiency
- 1 tablet thrice daily for first 4 days for acute hemorrhoid
- 1 tablet twice daily for 3 days for acute hemorrhoid
- 1 tablet once daily as maintenance dose for acute hemorrhoid
- 1 tablet once daily for 3 months for relapse of internal hemorrhoid & chronic hemorrhoid
- 1 tablet once daily for 2-6 months for chronic venous insufficiency
- 1 tablet once daily for 2 months for leg wounds
Administration
Tablet should be taken at meal times
Interaction
No evidence of drug incompatibility (drug interaction) has been reported in clinical trials
Contraindications
Contraindicated for anyone having a hypersensitivity to any ingredient in the product
Side effects
- Routine gastric disorders
- Neurovegetative disorders (feeling of discomfort)
Pregnancy lactation
- No teratogenic effect in animals
- No harmful effect reported in human beings
- Breastfeeding not recommended during treatment
Precautions warnings
- If the hemorrhoidal symptoms do not disappear within 15 days, patient should ask doctor for advice
- Not recommended for patients with a history of cancer
- Not recommended for breast cancer patients experiencing lymphedema
Therapeutic class
Phlebotonic & Vascular protecting preparation
Storage conditions
Keep below 30°C temperature, away from light & moisture, Keep out of the reach of children